DaVita Total Current Liabilities 2010-2024 | DVA

DaVita total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • DaVita total current liabilities for the quarter ending September 30, 2024 were $2.944B, a 16% increase year-over-year.
  • DaVita total current liabilities for 2023 were $2.642B, a 0.86% increase from 2022.
  • DaVita total current liabilities for 2022 were $2.62B, a 9.22% increase from 2021.
  • DaVita total current liabilities for 2021 were $2.399B, a 3.13% decline from 2020.
DaVita Annual Total Current Liabilities
(Millions of US $)
2023 $2,642
2022 $2,620
2021 $2,399
2020 $2,476
2019 $2,372
2018 $4,891
2017 $3,068
2016 $2,711
2015 $2,399
2014 $2,089
2013 $2,462
2012 $2,016
2011 $1,165
2010 $924
2009 $1,047
DaVita Quarterly Total Current Liabilities
(Millions of US $)
2024-09-30 $2,944
2024-06-30 $2,995
2024-03-31 $2,583
2023-12-31 $2,642
2023-09-30 $2,538
2023-06-30 $2,403
2023-03-31 $2,565
2022-12-31 $2,620
2022-09-30 $2,537
2022-06-30 $2,311
2022-03-31 $2,420
2021-12-31 $2,399
2021-09-30 $2,363
2021-06-30 $2,386
2021-03-31 $2,315
2020-12-31 $2,476
2020-09-30 $2,499
2020-06-30 $4,275
2020-03-31 $2,221
2019-12-31 $2,372
2019-09-30 $2,207
2019-06-30 $5,707
2019-03-31 $8,231
2018-12-31 $4,891
2018-09-30 $4,855
2018-06-30 $4,784
2018-03-31 $2,948
2017-12-31 $3,068
2017-09-30 $2,875
2017-06-30 $2,773
2017-03-31 $2,814
2016-12-31 $2,711
2016-09-30 $2,639
2016-06-30 $2,646
2016-03-31 $2,444
2015-12-31 $2,399
2015-09-30 $2,411
2015-06-30 $2,334
2015-03-31 $2,680
2014-12-31 $2,089
2014-09-30 $2,598
2014-06-30 $2,608
2014-03-31 $2,566
2013-12-31 $2,462
2013-09-30 $2,453
2013-06-30 $2,215
2013-03-31 $2,325
2012-12-31 $2,016
2012-09-30 $1,337
2012-06-30 $1,236
2012-03-31 $1,242
2011-12-31 $1,165
2011-09-30 $1,206
2011-06-30 $1,036
2011-03-31 $1,007
2010-12-31 $924
2010-09-30 $1,112
2010-06-30 $1,119
2010-03-31 $1,047
2009-12-31 $1,047
2009-09-30 $1,114
2009-06-30 $1,109
2009-03-31 $1,027
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.098B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00